Dudediligence.

Tilray Brands, Inc

TLRYNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$200.0MAug ’24$210.9MNov ’24$185.8MFeb ’25$224.5MMay ’25$209.5MAug ’25$217.5MNov ’25$206.7MFeb ’26$281.7MMay ’26
Net income, by quarter
−$39.2MAug ’24−$85.3MNov ’24−$789.4MFeb ’25−$1.27BMay ’25−$322,000Aug ’25−$44.9MNov ’25−$26.6MFeb ’26−$49.6MMay ’26
Fiscal years, by the month each ended
LineMay 2022May 2023May 2024May 2025May 2026
Revenue$628.4M$627.1M$788.9M$821.3M$915.5M
Gross profit$116.8M$147.0M$223.4M$240.6M$260.4M
Operating income−$610.4M−$1.37B−$174.7M−$2.28B−$63.0M
Net income−$476.8M−$1.45B−$245.0M−$2.19B−$121.4M
Operating cash flow−$177.3M$7.9M−$30.9M−$94.6M−$69.1M
Free cash flow−$211.3M−$12.9M−$60.2M−$127.5Mnone on file
Cash$415.9M$206.6M$228.3M$221.7M$226.0M
Debt$185.7M$23.4M$18.0M$7.2M$8.8M
Shares outstanding532.7M656.7M831.9M1.06B131.7M